|Chairman's<br>Statement|Chairman's<br>Statement|||||
|---|---|---|---|---|---|
|Vision||||||
|Mission||||||
|Pat's Story||||||
|Amy's Story||||||
|Directors'<br>and|Trustees'|Annual|Report||10|
|Introductory<br>Information|||||10|
|Strategic Report|||||13|
|Additional<br>Disclosures|||||23|
|Independent|Auditor's|Report|||30|
|Consolidated|Statement|of Financial||Activities||
|Consolidated|Balance Sheet||||35|
|Katharine<br>House Hospice Balance Sheet|||||36|
|Consolidated|Statement|of Cash Flow|||37|
|Notes to the|Cash Flow|Statement|||38|
|Notes to the|Financial Statements||||39 —59|












## 



## 



## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



|Year ended|2023|2022|2021|2020|2019|
|---|---|---|---|---|---|
|Inpatient<br>bed days|2,117|2,214|1,717|2,269|2,454|
|Inpatient<br>admissions|147|125|125|143|176|
|Day therapy<br>/ outpatient|163|Closed|Closed|1,853|2,053|
|attendances||||||
|Specialist nurse visits|1,283|1,286|486|1,071|242|
|Community<br>care contacts|5,579|5,998|6,376|6,521|6,806|
|Lymphoedema<br>treatments|1,667|1,404|514|1,685|1,593|
|Telephone/video<br>calls|13,123|12,964|15,992|6,760|4,820|



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

|Income Source|Gross income|Costs|Net contribution|%|FRcosts|
|---|---|---|---|---|---|
|||f|f|||
|Fundraising|837,470|275,345|562,866||32.8%|
|(Excl legacies)||||||
|2022:|898,342|248,388|649,954||27.6%|



## 




## 

## 

## 



## 

## 




## 

|Year ending|Year ending|2023|2022|2021|2020|2019|2018|
|---|---|---|---|---|---|---|---|
|Value|(f.000's)|574|601|584|499|609|618|
|Annual|Growth %|-4.5|29|170|-180|-1 5|-1 6|



## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 


## 



## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 



## 

## 

||||||2023|||2022|
|---|---|---|---|---|---|---|---|---|
|||Note|Unrestricted|Restricted|Totals|Unrestricted|Restricted|Totals|
||||E||E|E||E|
|INCOME|||||||||
|Donati ons and|Iega cies|(3)|1,801,340|169,901|1,971,241|1,648,782|139,256|1,788,038|
|Other trading activities||(4)|5,004,092||5,004,092|4,669,392||4,669,392|
|Charitable<br>activities||(5)|1,512,154|90,403|1,602,557|1,461,895|889,875|2,351,770|
|Investments||(6)|22,435||22,435|4,511||4,511|
|Other income||(7)|19,874|90|19,964|99,884||99,884|
|Total Income|||8,359,895|260,394|8,620,289|7,884,464|1,029,131|8,913,595|
|EXPENDITURE|||||||||
|Raising funds||( 8 )|3,672,810||3,672,810|3,425,158||3,425,158|
|Charitable<br>activities||( 8 )|3,355,814|305,268|3,661,082|2,249,416|952,046|3,201,462|
|Interest payable||||||8,828||8,828|
|Total Expenditure|||7,028,624|305,268|7,333,892|5,683,402|952,046|6,635,448|
|Net gains/(losses)<br>on investment|||(33,773)||(33,773)|21,185||21,185|
|assets|||||||||
|Net income / (expenses) before|||1,297,498|(44,874)|1,252,624|2,222,247|77,085|2,299,332|
|provisions|||||||||
|Provision<br>for|deferred tax liabilities||4,425||4,425|(1,045)||(1,045)|
|Net Movement|in Funds||1,301,923|(44,874)|1,257,049|2,221,202|77,085|2,298,287|
|RECONCILIATION|OF FUNDS||||||||
|Fund balances|broughtforward||6,917,294|144,604|7,061,898|4,696,092|67,519|4,763,611|
|Fund Balances Carried Forward||( 22 )|8,219,217|99,730|8,318,947|6,917,294|144,604|7,061,898|





## 

## 

||||||||2023|||2022|
|---|---|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
||||||Funds|Funds|Funds|Funds|Funds|Funds|
|||Note|||||E|||E|
|FIXED ASSETS|||||||||||
|Tangible assets||(|16 )||1,923,070||1,923,070|2,025,891||2,025,891|
|Investments||(|17 )||575,011||575,011|600,971||600,971|
||||||2,498,081||2,498,081|2,626,862||2,626,862|
|CURRENT ASSETS|||||||||||
|Debtors||(||18 )|1,372,723||1,372,723|995,608||995,608|
|Stock||(19)|||3,196||3,196|205||205|
|Cash at bank and in|hand||||5,077,082|99,730|5,176,812|3,874,882|144,604|4,019,486|
||||||6,453,001|99,730|6,5527731|4,870,695|144,604|5,015,299|
|CREDITORS|||(|20 )|(737,834)||(737,834)|(581,807)||(581,807)|
|Amounts<br>falling due within|||one year||||||||
|NET CURRENT ASSETS|||||5,715,167|99,730|5,814,897|4,288,888|144,604|4,433,492|
|TOTAL ASSETS LESS CURRENT|||||8,213,248|99,730|8,312,978|6,915,750|144,604|7,060,354|
|LIABILITIES|||||||||||
|CREDITORS|||||||||||
|Amounts<br>falling due after||one year|||||||||
|PROVISIONS<br>Deferred tax li abi liti es|||||5,969||5,969|1,544||1,544|
|TOTAL NET ASSETS|||||8,219,217|99790|8 918947|6917294|144 604|7,061,898|
|REPRESENTED BY:|||||||||||
|Restricted funds||||(22)||99,730|99,730||144,604|144,604|
|Designated<br>funds<br>Unrestricted<br>funds||||( 22 )|1,658,000<br>6,879,186||1,658,000<br>6,879,186|1,615,000<br>5,613,926||1,615,000<br>5,613,926|
|Subsidiary<br>retained|losses||||(317,969)||(317,969)|(311,632)||(311,632)|
||||||8,219,217|99,730|8,318,947|6,917,294|144,604|7,061,898|







## 

## 

|||||||||2023|||2022|
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|||||||Funds|Funds|Funds|Funds|Funds|Funds|
||||Note|||E||E||E|E|
|FIXED ASSETS||||||||||||
|Tangible assets|||(|16 )||1,923,070||1,923,070|2,018,091||2,018,091|
|Investments|||(||17 )|575,011||575,011|600,971||600,971|
|Investment|in|Group|(||17 )|5,602||5,602|5,602||5,602|
|||||||2,503,683||2,503,683|2,624,664||2,624,664|
|CURRENT ASSETS||||||||||||
|Debtors|||(||18 )|1,654,555||1,654,555|1,595,830||1,595,830|
|Cash at bank||and in hand||||4,712,720|99,730|4,812,450|3,434,126|144,604|3,578,730|
|||||||6,367,275|99,730|6,467,005|5,029,956|144,604|5,174,560|
|CREDITORS||||(|20 )|(651,741)||(651,741)|(425,694)||(425,694)|
|Amounts<br>falling||due within||one year||||||||
|NET CURRENT|ASSETS|||||5,715,534|99,730|5,815,264|4,604,262|144,604|4,748,866|
|TOTAL ASSETS|LESS CURRENT|||||8,219,217|99,730|8,318I947|7,228,926|144,604|7,373,530|
|LIABILITIES||||||||||||
|CREDITORS||||(20)||||||||
|Amounts<br>falling||due after|one yea r|||||||||
|TOTAL NET ASSETS||||||8,219,217|99,730|8,318,947|7,228I926|144,604|7,373,530|
|REPRESENTED|BY:|||||||||||
|Restricted|funds|||(22)|||99,730|99,730||144,604|144,604|
|Designated|funds|||( 22 )||1,658,000||1,658,000|1,615,000||1,615,000|
|Unrestricted||funds|||( 22 )|6,561,217||6,561,217|5,613,926||5,613,926|
|||||||8,219,217|99,730|8,318,947|7,228,926|144,604|7,373,530|






## 

## 

||||||||2023|2022|
|---|---|---|---|---|---|---|---|---|
|RECONCILIATION<br>OF OPERATING|PROFITTO OPERATING||CASH FLOWS||||||
|Net movement<br>in funds|||||||1,257,049|2,298,287|
|Deferred taxation|||||||(4,425)|1,045|
|Depreciation|||||||133,422|134,036|
|Loss/(gain)<br>on investment|assets||||||33,773|(21,185)|
|Income from fixed asset investment||||Note|i||(13,845)|(4,238)|
|Interest received||||Note|i||(8,590)|(273)|
|Interest payable on loans||||Note|i|||8,828|
|Loss/(gain)<br>on disposal|offixed|assets|||||22,696|(9,805)|
|Increase in debtors|||||||(377,115)|(473,932)|
|(Increase) / Decrease in stock|||||||(2,991)|606|
|Increase in creditors|||||||156,027|180,399|
|Net cash inflow from operating||activities|||||1,196,001|2,113,768|
|CASH FLOW STATEMENT|||||||||
|Net cash provided<br>by operating||activities|||||1,196,001|2,113,768|
|Returns<br>on investments|and servicing offinance|||Note||i|22,435|(4,317)|
||||||||1,218,436|2,109,451|
|(Purchase) / sale of fixed assets||||Note||i|(202,212)|45,524|
|Financing||||Note||i||(461,747)|
|Increase<br>in cash|||||||1,016,224|1,693,228|





## 

## 

## 

|NOTE<br>ITo THE CASH F|LOW STATEMENT|||||||
|---|---|---|---|---|---|---|---|
|||||||2023|2022|
|||||||f|f|
|Returns on investments<br>and servicing of finance||||||||
|Income from fixed|asset investments<br>in portfolio|||||13,845|4,238|
|Total income from|fixed asset investments|||||13,845|4,238|
|Other interest received|||Note|6||8,590|273|
|Interest payable<br>on loans|||||||(8,828)|
|||||||22,435|(4,317)|
|Financing||||||||
|Repayments<br>of<br>Ioan capita I|||||||(461,747)|
||||||||461747|
|Sale and purchase<br>offixed assets||||||||
|Purchase of tangible<br>fixed assets||||||(341,597)|(97,590)|
|Sale proceeds of other fixed assets||||||288,300|13,567|
|Purchase of fixed|asset investments|||||(584,842)|(184,571)|
|Proceeds ofsale offixed asset investments||||||435,927|314,118|
|||||||(202,212)|45,524|
|NOTE iiTo THE CASH|FLOW STATEMENT- Reconciliation|of Net|Cash Flow to|Movement|in Net Funds|||
|Net cash inflow||||||1,016,224|1,693,228|
|Change in net funds|in the year|||||1,016,224|1,693,228|
|Netfunds<br>at1April||||||4,164,580|2,471,352|
|Net funds at 31 March||||||5,180,804|4,164,580|
|NOTE iii TO THE CASH|FLOW STATEMENT -Analysis ofchanges||in net funds|||||
|||||As at||Cash|As at|
|||||1April 2022||Flows|31March 2023|
|Cash in hand and at|bank|||4,019,486||1,157,326|5,176,812|
|Cash in fixed asset investments||||145094||141102|3 992|
|TOTAL||||4,164,580||1,016,224|5,180,804|
|NOTE iv TO THE CASH|FLOW STATEMENT- Analysis ofChanges||in Net Debt|||||
|||||As at||Cash|As at|
|||||1April 2022||Flows|31March 2023|
|Cash at hand and in|bank|||4,019,486||1,157,326|5,176,812|
|Debt due within<br>1year||||||||
|Debt due after 1year<br>Cash In investments||||145094||141102|3 992|
|TOTAL||||4,164,580||1,016,224|5,180,804|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 




|.<br>INCOME F|ROM OTHER TR|ADING ACTIVITIES||||||
|---|---|---|---|---|---|---|---|
|||||2023|||2022|
|||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|Hospice||||||||
|KH Promotions|Ltd|65,005||65,005|253,216||253,216|
|KH Retail<br>Ltd||87,433||87,433|74,654||74,654|
|Sale of Donated|Goods|4,289,306||4,289,306|3,656,801||3,656,801|
|Gift Aid on Sale|of Goods|286,090||286,090|236,044||236,044|
|Fundraising<br>Events||51,540||51,540|79,613||79,613|
|||4,779,374||4,779,374|4,300,328||4,300,328|
|Group||||||||
|KH Promotions|Ltd|112,320||112,320|459,413||459,413|
|KH Retail<br>Ltd||264,836||264,836|237,521||237,521|
|Sale of Donated|Goods|4,289,306||4,289,306|3,656,801||3,656,801|
|Gift Aid on Sale|of Goods|286,090||286,090|236,044||236,044|
|Fundraising<br>Events||51,540||51,540|79,613||79613|
|||5,004,092||5,004,092|4,669,392||4,669,392|



## 

||||||2023|||2022|
|---|---|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|Hospice|||f|f|f|f|f|f|
|Integrated<br>Care Board (replaced<br>Gra nts||Local CI|inical Commissioning<br>Groups)<br>1,176,458||1,176,458|1,176,458||1,176,458|
|Contracts<br>Pension Rebate||(b)<br>(c)|||47,797<br>26,591||47,797<br>26,594|47,797<br>26,594|
|NHS England<br>Capa city Gra nt<br>(d)<br>Prison Services Contract<br>(e)<br>Stafford Borough Council<br>(f)<br>Other Fee Income<br>(g)<br>Income from Charitable<br>Activities|||3,500<br>1179,958|915<br>8 860<br>6,240<br>9D 4D3|915<br>8860<br>3,500<br>6,240<br>1,270 361|3,500<br>1179958|804,334<br>8,680<br>2,470<br>889,875|804,334<br>8,680<br>3,500<br>2,470<br>2 069,833|
|Group|||||||||
|Hospice-as<br>above|||1,179,958|90,403|] 27p 361|1,179,958|889,875|2 p6g 833|
|Embrace Quality<br>Care|||332,196||332 1g6|281,937||281 937|
|Group Income from Charitable||Activities|1,512,154|90,403|1,602,557|1,461,895|889,875|2,351,770|





## 

## 

|In additio|n,<br>the Hospic|e has received non-recurri|ng|gran|ts from local c|ouncils for specific obje|ctives, as desc|
|---|---|---|---|---|---|---|---|
|||||||2023|2022|
|||||||f||
|Cannock|Wood Parish|Council for IPU service||||500||
|Eccleshall Wood Parish Council for Therapy 8 Wellbeing|||||Centre|200||
|Gnosall|Parish Council|for Therapy 5 Wellbeing|Centre|||200||
|SCC local community||fund for Therapy 5 Wellbeing||Centre||2,625||
|Rugeley|Town Council|for IPU service|||||500|



## 

## 




## 

|OTHER INCOME||||||||
|---|---|---|---|---|---|---|---|
|||||2023|||2022|
|||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|||f|f|f|f|f|f|
|Hospice||||||||
|HMRC Job Retention<br>Scheme|||||19,468||19,468|
|Business<br>Rates Grants|||||58,001||58,001|
|Miscella neous||19,874|90|19,964|19,003||19,003|
|||19,874|90|19,964|96,472||96,472|
|Group<br>HMRC Job Retention<br>Scheme<br>Bus iness Rates<br>G ra nts|(a)||||21,931<br>58,001||21,931<br>58,001|
|Miscella neous|(b)|19,874<br>19814|90<br>90|19,964<br>19964|19,952<br>99884||19,952<br>99,884|
|(a) HMRC Job Retention<br>Scheme<br>Katharine<br>House Hospice<br>KH Promotions<br>Ltd|||||19,468<br>2463||19,468<br>2 463|
||||||21,931||21,931|
|(b) Miscellaneous<br>Katharine<br>House Hospice<br>Embrace Quality Care Ltd||19,874<br>19,874||19,874<br>19,874|19,003<br>949<br>19,952||19,003<br>949<br>19,952|





|||||N<br>tb<br>N0 0<br>N I-|N<br>tb<br>N0 0<br>N I-||CO<br>CO<br>OO<br>N<br>Ch<br>CO|CO<br>CO<br>OO<br>N<br>Ch<br>CO|CO<br>CO<br>OO<br>N<br>Ch<br>CO|Ch<br>o|CO<br>CO<br>IYl<br>CQ<br>(4<br>CO|CO<br>CO<br>IYl<br>CQ<br>(4<br>CO|||o<br>IA<br>I/1<br>00<br>N<br>(V<br>'d'<br>(4|o<br>IA<br>I/1<br>00<br>N<br>(V<br>'d'<br>(4|N<br>LD<br>CO<br>Gjo<br>Ch|o<br>Gj<br>o||ID<br>o<br>N|||||N<br>N<br>N|W|Ch<br>N|o<br>IA|N<br>LD<br>o|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||M|||||N|M||M||||||||||
|||||tb<br>CJ0|I/I0U<br>W<br> 00.|||||M<br>M<br>N<br>00<br>NN||N<br>N|LDoo||C<br>ID<br>CO<br>N<br>oo||o<br>CO<br>N|'LD<br>CO<br>(V<br>oo<br>N<br>M||||||0.<br>0<br>U||||||
||||||Uj|||||||||||||||||||||||||
|||||L.<br>CL|L<br>W<br>0<br>tb|||N<br>oo<br>cl'||||M<br>th<br>'CP<br>IA|||o<br>No||o<br>No|o<br>o|||||||M<br>N|W|CO<br>Vj|CO<br>Uj|COo<br>LD|
|||||QJ0|||||||||||||||||||||||||th|
|||||8 <br>P3|tl<br>w<br>GJ4d|||o<br>LD<br>M<br>IA<br>tE||||No<br>ID<br>tYl<br>th<br>Ch<br>th<br>tV|N<br>LA<br>00o<br>ID|||IAo<br>ID||o<br>IA<br>o<br>Lfj|LAo<br>N|||||||||||
|||||0||||||||||||||||||||||||||
|||||b|u|||M<br>CO<br>&4|CO<br>M<br>LA<br>LD|LD<br>N<br>CO||tel<br>CQ<br>tV<br>Ujo<br>CQ|||th<br>thooo<br>N|m<br>IDo<br>IO|N<br>o<br>o<br>N|CO<br>m<br>IA<br>N|O|o<br>00<br>N||t/I00|30<br>0|||||||
|||||N<br>O|u<br> 0I-|||IA<br>m<br>IA|U1<br>CON<br>IO|M<br>o||IA<br>m<br>IA<br>th<br>M|No<br>IO<br>o<br>CO||IA<br>CQ||LA<br>N|CO<br>rE<br>NN<br>IA||N<br>COo||0<br>GJ<br>IU0<br>bb|IU<br>C<br>GJ||N|W|CO <br>U<br>Ch|O<br>Ch|N<br>CD<br>00<br>Cho<br>Ch|
||||||||||ttj|||m|M|||||m||||0|CJ||||||N|
|||||||||||||||||||||||0|\-u|||||||
|||||GJ|||||ID||||||IA||ChN|I/1||||jO<br>GJ|G3|QJ||||||
|||||(I|00.0.||||LD<br>N|||IA<br>thN|||m<br>LA<br>m||th|M<br>Uj||||L.<br>QJ<br>0|0<br>IU<br>00|CL<br>0Z||||||
|||||L'J|IA<br> 0|||IO<br>U1|Gj<br>N|||U1<br>o|||N||N<br>N|||N<br>N||E0<br>C|'u0<br>IU<br>IUC||M<br>N|W|(V|CO<br> N||
|||||CL<br>GJ|IU|||rE|IA<br>U1|||tE<br>m|||LD||ID|||ID||GJ<br>IU|bO<br>QJ||||~ <br>O|o<br>M||
|||||CI||||||||||||||||||GJ|0||||M|||
||||||||||||||||||||||||GJ|||||||
|||||I/I<br>QJ <br>0|GJ<br> 0||||o<br>o|(4o<br>ID||m<br>M<br>NN|M(4o<br>N|||o<br>CO<br>o<br>Ch||o<br>LA<br>o|No<br>CO|o<br>CO<br>I/I||GJ<br>0<br>IU0<br>QJ<br>0<br>bO<br>'U|CJ<br>u<br>GI<br>0<br>0<br>QJ||||0<br>QI|||
|||||||||||||||||||||||C<br>IU|||||IUC|||
||||||||||||||||||||||||||||bb|||
|C <br>QJ <br>E <br>N <br>tU<br>(JC<br>C<br>tO<br>LJ<br>Ql<br>0<br>UJ<br>OJ <br>0|Ctj<br> O<br> (4<br>r<br>LJL<br> ~<br>C<br>l<br>CU<br>QJ<br>&<br>OJ<br> v <br>LJ|0|0.X|CI|W<br>u<br>IA<br>QJ<br>0z|CIz<br>Gz<br>Uj<br>0<br>Uj<br>0<br>U|GJ<br>8<br>Z|b0<br>C<br>t/I<br>L00<br>LL|ID<br>NJ<br>Gj<br>I<br>CJ<br>IU<br>bOC<br>13<br>IU<br>QJ<br>0|t/I<br>QJ<br>QJ<br>0<br>GJ<br>E<br>UO<br>IU<br>C<br>IU<br>E<br>0<br>CJ<br>E<br>t/I<br>IU<br>0|CL<br>0<br>Q<br>IO<br>N<br>tE<br>Gl<br>bOC<br>t/I<br>IU<br>00<br>LL<br>M<br>Ch<br>IO<br>CO<br>IU<br>bb0<br>IU<br>GJ<br>0||GJ<br>IU<br>0<br>QJ<br>E<br>QJ<br>ttO<br>0<br>E<br>0<br>GJ<br>E<br>GI<br>0<br>Gl<br>IDo|CD<br>xU<br>0<br>vj<br>0<br>U|0<br>X<br>ID<br>tV<br>QJ<br>IU<br>LJ<br>C<br>GJ<br>IU<br>CL|QJ<br>0<br>IU0<br>IU<br>0<br>U<br>N<br>IA||CL<br>0<br>U<br>IA<br>tV<br>(U<br>0<br>0<br>QJ<br>IU<br>CL|LA<br>tlat<br>M<br>LD<br>N<br>QJ<br>C<br>IU0<br>IU<br>0||l5z<br>z<br>0<br>z|C<br>4-<br>bO0<br>IU<br>0<br>0<br>IUi-i-<br>C<br>I<br>0<br>CJ0.<br>X<br>IU|C)<br>QJ<br>IUC<br>GJ<br>IU<br>GI<br>0<br>CJ<br>CL<br>X<br>GJ<br>(U<br>IU<br>CJ<br>0<br>GJ<br>IU<br>D<br>Ct||||GJ<br>GJ<br>LJ<br>t/I u<br>C<br>CC|||





## 

## 


## 



## 

|11.|TRADING|SUBSIDIARIES (Cont. )|SUBSIDIARIES (Cont. )||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||KH Promotions||Ltd|KH Retail||Ltd||
|||||||2023||2022|2023|||2022|
|||||||f||f|f|||f|
||Turnover|(including<br>HMRC Job Retention|||Scheme)|112,320|461,876||264,836||237,521||
||Direct operating||costs|||(47,329)|(208,665)||(221,612)||(199,685)||
||Net recharges<br>to/(from)<br>Katharine|||House Hospice|||||39,784||28,124||
||Gross Profit|||||64,991|253,211||83,008||65,960||
||Interest receivable|||||14|||||||
||Taxation||||||||4,425||(1,045)||
||Net profit|before|Gift Aid|||65,005|253,216||87,433||64,915||
||Distribution<br>under Gift Aid to Katharine||||House|(65,005)|(253,216)||(87,433)||(74,654)||
||Retained|in subsidiary<br>undertaking||||||||||(9,739)|
||Retained|earnings<br>broughtforward||||||||||9,739|
||Retained|earnings<br>carried forward|||||||||||
||The aggregate<br>of||the assets, liabilities||and funds at31 March was:||||||||
||||Fixed assets|||||||||7,800|
||||Current assets|||65,579||153,931|325,490||307,358||
||||Current liabilities|||(65,479)|(153,831)||(325,488)||(315,156)||
||||Total Assets|||100||100|||||
||||Share capital|||100||100|||||
||||Funds|||100||100||2||2|
|||||||Embrace Quality||Care Ltd|KHH|Development||Ltd|
|||||||2023||2022|2023|||2022|
|||||||f||f||f||f|
||Turnover|(including<br>HMRC JRS5 Misc|||Income)|332,196||282,886|||||
||Direct operating||costs|||(338,533)|(291,600)||||||
||Retained|in subsidiary<br>undertaking||||(6,337)||(8,714)|||||
||Retained|earnings<br>broughtforward||||(311,632)|(302,918)||||||
||Retained|earnings<br>carried forward||||~317969|~311,632||||||
||The aggregate<br>ofthe assets, liabilities||||and funds at 31March was:||||||||
||||Current assets|||48,269||42,994||500||500|
||||Current liabilities|||(361,238)|(349,626)||||||
||||Total Assets|||(312,969)|(306,632)|||500||500|
||||Share capital|||5,000||5,000||500||500|
||||Retained earnings|||(317,969)|(311,632)||||||
||||Funds|||(312,969)|(306,632)|||500||500|





## 

## 

|The number<br>ofstaff and|whole t|ime equivalents<br>employed|by the Charity,<br>ana|lysed<br>by function|was:||
|---|---|---|---|---|---|---|
|Company||2023|||2022||
|||Average|Whole time|Average||Whole time|
|Care services||Employees<br>71|Equival ent<br>50.64|Em pl oyees<br>67||Equivalent<br>46.39|
|Support and overheads||36|24.72|32||24.09|
|Income generation||117<br>224|73.39<br>148.75|120<br>219||70.61<br>141.09|
|Group||Average<br>2023|Whole time|Average|2022|Whole time|
|||Employees|Equival ent|Emp<br>Ioyees||Equivalent|
|Care servi ces||88|65.70|85||59,52|
|Support and overheads||36|24.72|32||24.09|
|Income generation||122<br>246|78.71<br>169.13|126<br>243||76.37<br>159.98|
|The costs of employment|were:||||||
|||2023<br>Company|2022|2023|Group|2022|
|||f|f|f||f|
|Salary||4,235,713|3,793,626|4,584,055||4,117,330|
|National<br>Insurance||337,922|273,166|359,638||291,239|
|Pension||223,390|171,063|232,354||179,314|
|||4,797,025|4,237,855|5,176,047||4,587,883|
|Bought-in staff||149,743|145,563|149,743||145,563|
|||4,946,768|4,383,418|5,325,790||4,733,446|



## 

## 

|The numb|er<br>ofstaff whose em|oluments<br>during the year|exceeded f60,00|0was:|||
|---|---|---|---|---|---|---|
|||Company|||Group||
|||2023|2022|2023||2022|
|f60,001|—f70,000|1|0|0||0|
|f70,001|—f80,000|0|0|0||0|
|f80,001|—f90,000|1|1|1||1|





## 

## 

## 

## 

## 

||||2023|||2022||
|---|---|---|---|---|---|---|---|
|||Average||Employer|Average||Employer|
|Company||Number||Contribution<br>f|Number||Contribution<br>f|
|NHS||21||87,540|21||83,228|
|Standard|Life|13||38,206|14||41,969|
|NEST||158||97,644|138||81,862|
|||192||223,390|173||207,059|
|Group<br>NHS||21||87,540|21||83,228|
|Standard|Life|13||38,206|14||41,969|
|NEST||177||106,608|152||87,723|
|||211||232,354|187||212,920|





## 

|||Long Leasehold|Equipment,||||
|---|---|---|---|---|---|---|
|||Land and|Furniture|ITEquipment|Motor||
|COMPANY||Buildings<br>f|and Fixtures|and Software<br>f|Vehicles<br>f|Total<br>f|
|Cost|||||||
|At 1April 2022||2,748,707|476,201|184,837|103,093|3,512,838|
|Addi tions||258,576|45,258|37,763||341,597|
|Disposals||(422,950)|(111,301)|(35,304)||(s69,sss)|
|At 31March 2023||2,584,333|410,158|187,296|103,093|3,284,880|
|Depreciation|||||||
|At1April|2022|911,684|403,520|166,578|12,965|1,494,747|
|Charge for the year||57,371|33,324|15,407|19,520|125,622|
|Dispos a Is||(114,241)|(109,014)|(35,304)||(258,559)|
|At 31March 2023||854,814|327,830|146,681|32,485|1,361,810|
|Net BookValue|||||||
|At 31March 2023||1,729,519|82,328|40,615|70,608|1,923,070|
|At1April|2022|1,837,023|72,681|18,259|90,128|2,018,091|
|GROUP|||||||
|Cost|||||||
|At 1April|2022|2,802,629|476,201|184,837|216,398|3,680,065|
|Addi tions||258,576|45,258|37,763||341,597|
|Disposals||(422,950)|(111,301)|(35,304)|(15,210)|(584,765)|
|At 31 March 2023||2,638,255|410,158|187,296|201,188|3,436,897|
|Depreciation|||||||
|At 1 April|2022|965,606|403,520|166,578|118,470|1,654,174|
|Charge for the year||57,371|33,324|15,407|27,320|133,422|
|Dispos a<br>I|s|(114,241)|(109,014)|(35,304)|(15,210)|(273,769)|
|At 31 Ma|rch 2023|908,736|327,830|146,681|130,580|1,513,827|
|Net Book Value|||||||
|At 31March 2023||1,729,519|82,328|40,615|70,608|1,923,070|
|At 1April|2022|1,837,023|72,681|18,259|97,928|2,025,891|





## 

## 

## 


## 




## 

## 

|DEBTORS||||||||
|---|---|---|---|---|---|---|---|
|||||Company||Group||
|||||2023|2022|2023|2022|
|||||f|f|f|f|
|Intercompany|accounts|||353,612|663,744|||
|Trade debtors||||669,518|556,962|713,763|588,149|
|NHS pharmaceutical|||supplies|11,080|3,874|11,080|3,874|
|HMRC<br>—tax and||social security||210,528|160,664|210,528|160,664|
|Other debtors||||6,869|1,184|34,404|33,519|
|Accrued legacy||income||248,091|62,572|248,091|62,572|
|Prepayments||||150,982|142,955|150,982|142,955|
|Deposits<br>provided||||3,875|3,875|3,875|3,875|
|||||1,654,555|1,595,830|1,372,723|995,608|



## 

|19.|STOCK|||||
|---|---|---|---|---|---|
|||Company||Group||
|||2023|2022|2023|2022|
|||||f|f|
||Bought in goods|||3,196|205|
|20.|CREDITORS|||||



|Amounts|due in under one year||Company||Group||
|---|---|---|---|---|---|---|
||||2023|2022|2023|2022|
|||Note|f|f|f|f|
|Payments|on account||||53,552|120,107|
|Trade creditors|||229,173|202,669|255,158|232,206|
|HMRC|||144,896|76,053|145,676|76,053|
|Accruals|||201,430|123,588|204,863|126,999|
|Deferred|income|(21)|40,519|17,301|40,519|17,301|
|Other creditors|||35,723|6,083|38,066|9,141|
||||651,741|425,694|737,834|581,807|
|Amounts|due after one year||Company||Group||
||||2023|2022|2023|2022|
||||f|f|||
|Bank loans|||||||





## 

## 


## 

## 



## 

## 

|COMPANY|COMPANY|COMPANY|COMPANY|||||||
|---|---|---|---|---|---|---|---|---|---|
|For the Year Ended 31March 2023||||||||Transfer||
|||||Opening|||Investment|from / (to)|Closing|
|||||Fund|||Gains /|General|Fund|
|Funds||||Value<br>f|Income|Expenditure<br>f|(Losses)<br>f|Fund<br>f|Value<br>f|
|General<br>Fund||||5,613,926|6,904,461|(6,142,875)|(33,773)|537,447|6,879,186|
|Designated<br>Funds||||||||||
|Renovation/Refurbi<br>shment <br>Centre||Thera py||250,000||(194,744)||(256)|55,000|
|Norton<br>Bridge Renovation||||70,000||(63,832)||(6,168)||
|Refurbishment<br>of retail|premises|||||||75,000|75,000|
|Provn for dilapidations|retail||premises|||||100,000|100,000|
|Acquistion<br>86 Refurbishment|||of Property|1,100,000||||200,000|1,300,000|
|Renewa<br>I of IT||||65,000||(47,597)||12,597|30,000|
|Training<br>and Development||||10,000||(11,886)||67,886|66,000|
|Replacement<br>ofclinical|system|||||||25,000|25,000|
|Replacement<br>oftelephone||system||||||7,000|7,000|
|Legacy Equalisation||||120000|898506|||~1018506||
|||||1,615,000|898,506|(318,059)||(537,447)|1,658,000|
|Restricted<br>Funds||||||||||
|Capital<br>and Equipment|Funds|||102,542|145,792|(193,291)|||55,043|
|NHSE Capa city Funding<br>Service Funds<br>Other Restricted<br>Funds||||14,012<br>28050|915<br>105,222<br>8465|(915)<br>(105,429)<br> ~5633|||13,805<br>30882|
|||||144,604|260I394|(305,268)|||99,730|
|||||7373530|8 063361|~6766 202|~33 773||8 636,916|
|For the Year Ended 31March||2022||||||Transfer||
|||||Opening|||Investment|from / (to)|Closing|
|||||Fund|||Gains /|General|Fund|
|Funds||||Value<br>f|Income|Expenditure<br>f|(Losses)f|Fund<br>f|Value<br>f|
|General<br>Fund||||3I519,655|6,311,513|(4,513,722)|21,185|275,295|5,613,926|
|Designated<br>Funds||||||||||
|Repairs and Renewals||||100,000||(22,379)||(77,621)||
|Renovation/Refurbishment||Therapy||||||250,000|250,000|
|Norton<br>Bridge Renovation||||||||70,000|70,000|
|Acquistion<br>84 Refurbishment|||of Property|||||1,100,000|1,100,000|
|Renewal of IT||||100,000||||(35,000)|65,000|
|Trai ning and Devel opment<br>Legacy Equalisation||||7,978<br>120,000|918,533|(9,127)||11,149<br>(918,533)|10,000<br>120,000|
|Loan Repayments<br>Emergency<br>Campaign||||467,328<br>674 310||(466,348)||(980)<br>~674 310||
|||||1,469,616|918,533|(497,854)||(275,295)|1,615,000|
|Restricted<br>Funds||||||||||
|Capital<br>and Equipment|Funds|||28,927|96,589|(22,974)|||102,542|
|NHSE Capacity Funding|||||804,334|(804,334)||||
|Service Funds<br>Other Restricted<br>Funds||||14,883<br>23 709|116,806<br>11402|(117,677)<br> ~7061|||14,012<br>28050|
|||||67,519|1,029,131|(952,046)|||144,604|
|||||5 056 790|8 259 177|~5963622|21185||7373530|





## 

## 

## 

## 

|For the|Year Ended 31March 2023|Year Ended 31March 2023||||Investment|||
|---|---|---|---|---|---|---|---|---|
|||||||Gains /|Transfer||
||||Opening|||(Losses)|from / (to)|Closing|
||||Fund|||and|General|Fund|
|Funds|||Value|Income|Expenditure|Provisions|Fund|Value|
||||f||f||f|f|
|General|Fund||5,302,294|7,461,389|(6,710,565)|(29,348)|537,447|6,561,217|
|Designated||Funds|1,615,000|898,506|(318,059)||(537,447)|1,658,000|
|Restricted||Funds|144,604|260,394|(305,268)|||99,730|
||||7 061898|8 620 289|~7333 892|~29 348||8318947|
|For the|Year Ended 31March 2022|||||Investment|||
|||||||Gains /|Transfer||
||||Opening|||(Losses)|from / (to)|Closing|
||||Fund|||and|General|Fund|
|Funds|||Value|Income|Expenditure|Provisions|Fund|Value|
||||f||f||f|f|
|General|Fund||3,226,476|6,965,931|(5,185,548)|20,140|275,295|5,302,294|
|Designated||Funds|1,469,616|918,533|(497,854)||(275,295)|1,615,000|
|Restricted||Funds|67,519|1,029,131|(952,046)|||144,604|
||||4763611|8913595|~6635 448|20 140||7061898|



## 

## 

## 



## 

## 


## 

## 

|Caroline Bruckner<br>Holt (Medical Director of Katharine<br>House Hospice), Zia Din (Trustee of Katharine|Caroline Bruckner<br>Holt (Medical Director of Katharine<br>House Hospice), Zia Din (Trustee of Katharine|Caroline Bruckner<br>Holt (Medical Director of Katharine<br>House Hospice), Zia Din (Trustee of Katharine|Caroline Bruckner<br>Holt (Medical Director of Katharine<br>House Hospice), Zia Din (Trustee of Katharine|Caroline Bruckner<br>Holt (Medical Director of Katharine<br>House Hospice), Zia Din (Trustee of Katharine|Caroline Bruckner<br>Holt (Medical Director of Katharine<br>House Hospice), Zia Din (Trustee of Katharine|Caroline Bruckner<br>Holt (Medical Director of Katharine<br>House Hospice), Zia Din (Trustee of Katharine|House Hospice),|Richard|
|---|---|---|---|---|---|---|---|---|
|Hughes<br>(Trustee of Katharine<br>House Hospice) &Jenny Clarke (Trustee of Katharine||||||House Hospice)|||
|County Hospital<br>and University<br>Hospitals ofthe North||Midlands||(formerly|Mid|Staffordshire|||
|Hospitals|NHSTrust)<br>(relationship:<br>Employees)||||||||
|Provision|of pharmacy<br>services and drug supplies||||||63,754|58,875|
|Provision|of palliative<br>medical consultant<br>sessions||||||120,155|114,332|
|Contract|for the provision<br>of occupational<br>and physiotherapy||services||||20,179|33,310|
|Provision|of I-Portal||||||10,019||
|Provison|oftraining<br>courses||||||600||
||Outstanding<br>Creditor|Balance|as|at 31st|March||52,881|46,337|
|Jennifer Woodyard<br>(Trustee of Katharine<br>House Hospice)|||||||||
|Hand Morgan<br>g. Owen Solicitors (relationship:<br>Employee)|||||||||
|Provision|of legal services connected<br>with property<br>transactions||||||||
||Outstanding<br>Creditor|Balance|as|at 31st|March||||





|RELATED|PARTY TR|ANSACTIONS|(Cont.)||||
|---|---|---|---|---|---|---|
||||||2023|2022|
||||||f|f|
|Stephen|Paul Kirwan|(Trustee of|Katharine<br>House Hospice)||||
|Nowell<br>Mellor Solictors (relationship:<br>Employee)|||||||
|Provision<br>of legal||services connected<br>with property||transactions|2,584||
||||Outstanding<br>Creditor Balance as at 31st March||||
|Richard|Soulsby (CEO of Katharine||House Hospice)||||
|AL Services (relationship:<br>Spouse is proprietor)|||||||
|Spot|purchasing|ofcounselling|services||1,990|1,463|
||||Outstanding<br>Creditor Balance as at 31st March||||



## 

